Effects of pessary versus surgery in patients with symptomatic pelvic organ prolapse: a systematic review and meta-analysis

To compare the effectiveness and safety of pessary versus surgery in symptomatic pelvic organ prolapse. This PRISMA 2020-compliant meta-analysis (PROSPERO: CRD420251109479) searched PubMed, Embase, Web of Science, and Cochrane Library (inception: June 2025) for randomized controlled trials (RCTs) and cohort studies comparing pessary versus surgery in symptomatic POP patients. The primary outcomes included Patient Global Impression of Improvement (PGI-I) and Severity (PGI-S), pelvic floor distress inventory (PFDI-20), and related subscales (CRADI-8, UDI-6, POPDI-6). The secondary outcomes included pelvic floor impact (PFIQ-7), sexual function (PISQ-IR), and complications (e.g., urinary tract infection). Risk of bias was assessed using Cochrane tools (RCTs) and Newcastle–Ottawa Scale (cohorts). Data were pooled using random-effects models (RevMan 5.4.1), reporting standardized mean differences (SMD) or risk ratios (RR) with 95% confidence intervals (CI). Seven studies ( n = 1261 patients) were included. Surgery showed significantly greater improvement than pessary in: PGI-I (RR: 0.93; 95% CI 0.87–0.99; P = 0.03), PGI-S (RR: 0.79; 95% CI 0.66–0.96; P = 0.02), PFDI-20 (SMD: 0.23; 95% CI 0.10–0.37; P = 0.0005), CRADI-8 (SMD: 0.27; 95% CI 0.11–0.42; P = 0.001), and UDI-6 (SMD: 0.23; 95% CI 0.07–0.39; P = 0.005). However, the significance of some of the results depends on the specific study, suggesting that the conclusions should be interpreted with caution. No significant differences were found in PFIQ-7, PISQ-IR sexually active, POPDI-6, or urinary tract infection. Sensitivity analyses indicated the PGI-I and PFDI-20 superiority of surgery depended on specific studies. No publication bias was detected (Egger’s test P > 0.05). Surgical intervention demonstrates superior improvement in patient-reported symptom severity (PGI-S), global improvement (PGI-I), and specific pelvic floor distress (PFDI-20, CRADI-8, UDI-6) compared to pessary for symptomatic POP. However, both treatments showed comparable effects on quality-of-life impact (PFIQ-7), sexual function (PISQ-IR), and specific complications. Treatment choice should be individualized, considering patient factors and preferences.

Authors

Institutions

Publication Details

Journal
Archives of Gynecology and Obstetrics
Published
2026-11-17
DOI
https://doi.org/10.1007/s00404-026-08575-0
Primary Topic
Pelvic floor disorders treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of pessary versus surgery in patients with symptomatic pelvic organ prolapse: a systematic review and meta-analysis

Qiao Du, Qixin Wang, Shuo Yang
Archives of Gynecology and Obstetrics
Pelvic floor disorders treatments
article

Effects of pessary versus surgery in patients with symptomatic pelvic organ prolapse: a systematic review and meta-analysis

Qiao Du, Qixin Wang, Shuo Yang
article en

Abstract

To compare the effectiveness and safety of pessary versus surgery in symptomatic pelvic organ prolapse. This PRISMA 2020-compliant meta-analysis (PROSPERO: CRD420251109479) searched PubMed, Embase, Web of Science, and Cochrane Library (inception: June 2025) for randomized controlled trials (RCTs) and cohort studies comparing pessary versus surgery in symptomatic POP patients. The primary outcomes included Patient Global Impression of Improvement (PGI-I) and Severity (PGI-S), pelvic floor distress inventory (PFDI-20), and related subscales (CRADI-8, UDI-6, POPDI-6). The secondary outcomes included pelvic floor impact (PFIQ-7), sexual function (PISQ-IR), and complications (e.g., urinary tract infection). Risk of bias was assessed using Cochrane tools (RCTs) and Newcastle–Ottawa Scale (cohorts). Data were pooled using random-effects models (RevMan 5.4.1), reporting standardized mean differences (SMD) or risk ratios (RR) with 95% confidence intervals (CI). Seven studies ( n = 1261 patients) were included. Surgery showed significantly greater improvement than pessary in: PGI-I (RR: 0.93; 95% CI 0.87–0.99; P = 0.03), PGI-S (RR: 0.79; 95% CI 0.66–0.96; P = 0.02), PFDI-20 (SMD: 0.23; 95% CI 0.10–0.37; P = 0.0005), CRADI-8 (SMD: 0.27; 95% CI 0.11–0.42; P = 0.001), and UDI-6 (SMD: 0.23; 95% CI 0.07–0.39; P = 0.005). However, the significance of some of the results depends on the specific study, suggesting that the conclusions should be interpreted with caution. No significant differences were found in PFIQ-7, PISQ-IR sexually active, POPDI-6, or urinary tract infection. Sensitivity analyses indicated the PGI-I and PFDI-20 superiority of surgery depended on specific studies. No publication bias was detected (Egger’s test P > 0.05). Surgical intervention demonstrates superior improvement in patient-reported symptom severity (PGI-S), global improvement (PGI-I), and specific pelvic floor distress (PFDI-20, CRADI-8, UDI-6) compared to pessary for symptomatic POP. However, both treatments showed comparable effects on quality-of-life impact (PFIQ-7), sexual function (PISQ-IR), and specific complications. Treatment choice should be individualized, considering patient factors and preferences.

Archives of Gynecology and Obstetrics
Ningbo University Affiliated Hospital (CN)
Good health and well-being
Pelvic floor disorders treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon